Table 3.
Subgroup features.
| Parameter | High initial viability >80% | Low initial viability <80% |
|---|---|---|
| Mean ± SEM | Mean ± SEM | |
| Number of cases | 22 | 5 |
| Surgical Indication | ||
| HCC | 2 | 0 |
| Biliary tree carcinoma | 6 | 4 |
| CRLM | 12 | 0 |
| Benign disease | 2 | 1 |
| Preoperative bilirubin | 0.65 ± 0.08 | 1.21 ± 0.49 |
| Preoperative ALT | 35.32 ± 4.98 | 63.00 ± 19.99 |
| Preoperative AST | 41.24 ± 6.10 | 45.60 ± 4.41 |
| Preoperative AP | 152.50 ± 41.62 | 320.60 ± 108.62 |
| Preoperative GGT | 215.05 ± 59.80 | 356.80 ± 133.79 |
| Preoperative INR | 1.02 ± 0.01 | 1.04 ± 0.02 |
| Age of donor (years) | 61.50 ± 3.13 | 57.40 ± 7.69 |
| Fibrosis | ||
| No Fibrosis | 5 | 0 |
| Minimal (periportal) | 6 | 2 |
| Mild (septs) | 4 | 3 |
| Severe Fibrosis (portocentral septs, architecture changes) | 2 | 0 |
| Cirrhosis (definite architectural changes) | 1 | 0 |
| Data not available | 4 | 0 |
| Steatosis | ||
| No Steatosis | 2 | 0 |
| ≤30% Steatosis | 8 | 0 |
| >30% Steatosis | 3 | 0 |
| Data not available | 9 | 5 |
| Cold ischeamic time (min) | 23.27 ± 3.51 | 15.00 ± 2.24 |
| Time of first perfusion (min) | 11.18 ± 0.56 | 10.50 ± 0.61 |
| Time of second perfusion (min) | 8.09 ± 0.28 | 8.00 ± 0.57 |
| Mass of liver specimen (g) | 16.34 ± 1.39 | 26.42 ± 13.42 |
Abbreviations: GGT, Gamma-glutamyl transpeptidase; CIT, cold ischemic time; AST, aspartate aminotransferase; ALT, alanine aminotransferase; AP, alkaline phosphatase; INR, international normalized ratio; HCC, Hepatocellular carcinoma; CRLM, Colorectal liver metastasis.